Related Experiment Video
Updated: Sep 23, 2025
A Mouse Model of Chronic Liver Fibrosis for the Study of Biliary Atresia
Published on: February 3, 2023
Current Understanding in the Clinical Characteristics and Molecular Mechanisms in Different Subtypes of Biliary
Lin He1, Patrick Ho Yu Chung2, Vincent Chi Hang Lui2
1Cancer Centre, Faculty of Health Sciences, University of Macau, Macau SAR, China.
Insights
Biliary atresia (BA) is a serious infant liver disease. This study classifies BA subtypes, revealing distinct clinical features and molecular causes to guide tailored treatments for better outcomes.
Area of Science:
- Pediatric Hepatology
- Gastroenterology
- Neonatal Medicine
Background:
- Biliary atresia (BA) is a leading cause of surgical jaundice and pediatric liver transplantation.
- Existing classifications lack specificity for targeted therapies.
- Understanding BA subtypes is crucial for improving patient prognosis.
Purpose of the Study:
- To propose a precise clinical classification of biliary atresia.
- To review clinical characteristics and molecular mechanisms of different BA subtypes.
- To establish a basis for subtype-specific management protocols.
Main Methods:
- Review of clinical data from various biliary atresia subtypes.
- Analysis of molecular mechanisms contributing to BA development.
- Comparative study of clinical manifestations across BA classifications.
Main Results:
- A refined classification including isolated BA (IBA), cystic BA (CBA), syndromic BA (SBA), and cytomegalovirus-associated BA (CMVBA).
- Identification of distinct clinical presentations for each BA subtype.
- Elucidation of molecular contributors specific to different BA forms.
Conclusions:
- Biliary atresia exhibits significant clinical and etiological heterogeneity.
- Subtype-specific understanding is essential for developing tailored treatment strategies.
- This classification facilitates personalized management for improved pediatric liver disease outcomes.
Abstract:
Biliary atresia is a severe obliterative cholangiopathy in early infancy that is by far the most common cause of surgical jaundice and the most common indicator for liver transplantation in children. With the advanced knowledge gained from different clinical trials and the development of research models, a more precise clinical classification of BA (i.e., isolated BA (IBA), cystic BA (CBA), syndromic BA (SBA), and cytomegalovirus-associated BA (CMVBA)) is proposed. Different BA subtypes have similar yet distinguishable clinical manifestations. The clinical and etiological heterogeneity leads to dramatically different prognoses; hence, treatment needs to be specific. In this study, we reviewed the clinical characteristics of different BA subtypes and revealed the molecular mechanisms of their developmental contributors. We aimed to highlight the differences among these various subtypes of BA which ultimately contribute to the development of a specific management protocol for each subtype.
